This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

SUAT ÇAAYAN, MD; FIGEN KOLOLU, MD
Sosval Sigortalar Tepecik Teaching Hospital Yenisehir Izmir, Turkey

Am J Dis Child. 1988;142(10):1022-1023.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Sir.—Therapeutic use of intravenous immunoglobulin has been recommended for the treatment of acute and chronic idiopathic thrombocytopenic purpura¹ and neonatal sepsis.^2,3 For prophylactic purposes, we infused 0.5 g of intravenous immunoglobulin (Sandoglobulin, Sandoz LTD, Basel, Switzerland) into healthy premature infants with birth weights of 1500 to 2000 g. Freshly dissolved immunoglobulin solutions were used, but for economic reasons the remainder of two bottles of immunoglobulin solutions was not discarded. These residues were stored at – 4°C to – 10°C for five and six days, respectively. The frozen solutions were rethawed and warmed to room temperature just before use. On infusion into two premature infants, we observed two anaphylactic reactions; one was lethal.

Patient Reports.—PATIENT 1.—A 1-day-old male infant (birth weight, 1700 g) was given 0.5 g of five-day-old immunoglobulin solution. It was infused slowly, at a rate of about seven to eight drops per minute. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?